Sedatives, Analgesics, Opioids, and Reversal

Pain control is also respiratory assessment

Phase I pain management is never only a pain score. Interpret pain intensity alongside respiratory rate, depth, oxygen saturation, end-tidal carbon dioxide (EtCO2) when available, airway tone, blood pressure, a sedation score, the procedure, and comorbidities. A patient reporting 8/10 pain with strong respiratory effort may need analgesia; a patient with the same score who is somnolent and hypoventilating needs the ventilation risk addressed before any more opioid.

Opioids depress ventilatory drive, blunt airway reflexes, and stack onto residual volatile or intravenous anesthetic. Opioid-induced ventilatory impairment appears as a rising EtCO2 and falling rate before saturation drops, especially when supplemental oxygen masks the decline. Older adults, patients with obstructive sleep apnea, those also receiving benzodiazepines or gabapentinoids, and opioid-naive patients deteriorate fastest. The exam rewards the answer that reassesses sedation and ventilation before repeating a dose.

Common medication patterns

Drug effects overlap with generic PACU problems. Nausea may follow opioids or volatile agents; pruritus often follows neuraxial opioids; hypotension may reflect propofol, neuraxial sympathectomy, bleeding, or dehydration. Sort by timing, trend, procedure, and associated findings rather than reflex.

Multimodal thinking

Multimodal analgesia combines mechanisms: acetaminophen, NSAIDs when appropriate, regional or local infiltration, ice, positioning, distraction, and carefully titrated opioids. CPAN judgment is knowing when an adjunct helps and when it is unsafe. A patient with renal impairment, active surgical bleeding risk, or gastric ulcer history is a poor candidate for routine NSAIDs. A patient with cirrhosis or heavy alcohol use needs a reduced acetaminophen ceiling.

A numb limb from a block does not prove global comfort, and severe pain despite a functioning block can flag block failure, compartment syndrome, or ischemia, so compare the pain pattern with the expected surgical and block distribution.

Reversal agents

Naloxone reverses opioid-induced respiratory depression. Titrate small IV doses (e.g., 0.04-0.1 mg diluted) to restore an adequate respiratory rate rather than full wakefulness, because abrupt full reversal can trigger severe pain, a sympathetic surge with hypertension and tachycardia, vomiting, flash pulmonary edema, or acute withdrawal in opioid-dependent patients. Its duration (roughly 30-90 minutes) is often shorter than the opioid it reverses, so re-narcotization is a real risk and monitoring must continue.

Flumazenil reverses benzodiazepine sedation but can precipitate seizures in benzodiazepine-dependent patients or mixed overdoses and is contraindicated when a proconvulsant co-ingestion is suspected. It does nothing for opioid respiratory depression, residual volatile gas, hypoglycemia, stroke, or residual neuromuscular blockade. Like naloxone, its effect can wane before the agonist clears.

Exam decision pattern

When a stem mixes sedation, pain, and changing respirations, rank the problem. First, keep the airway open and ventilation adequate (stimulate, reposition, support, give oxygen, assist ventilation). Second, identify the medication contribution and hold further depressants. Third, notify anesthesia or the provider when rescue medication, assisted ventilation, or unexpected neurologic change is needed. Finally, reassess pain and reach for safer multimodal options once oxygenation and ventilation are stable. The wrong answer almost always gives more opioid to a sedated, hypoventilating patient because the number on the pain scale was high.

Sedation scoring and titration discipline

The CPAN nurse documents sedation on a validated scale such as the Pasero Opioid-Induced Sedation Scale (POSS) or the Richmond Agitation-Sedation Scale (RASS), because a rising sedation level precedes respiratory depression. On the POSS, a patient who is frequently drowsy and drifts off to sleep during conversation signals that the next opioid dose should be held or reduced and ventilation monitored, while a somnolent patient with minimal or no response to stimulation requires holding the opioid, stimulation, oxygen, and possible naloxone.

Titrating to sedation rather than to the pain number prevents the most common preventable PACU event: opioid stacking in a patient who is already too sleepy to protect ventilation.

Distinguish agent half-lives when interpreting a stem. Fentanyl is short-acting (30-60 minutes) but redistributes, hydromorphone and morphine last hours and morphine's active metabolite accumulates in renal failure, and midazolam's effect is prolonged in older adults and hepatic impairment. A patient who looked fine at handoff can deteriorate as a longer agent peaks, so reassessment after every dose and at fixed intervals, not just on arrival, is the safe practice the exam tests.

One more high-yield distinction: nausea and vomiting in Phase I is itself a safety problem, not only a comfort issue, because vomiting risks aspiration, raises intracranial and intraocular pressure, and stresses fresh suture lines. Treat postoperative nausea with ordered antiemetics that target different receptors, ondansetron, dexamethasone, and a scopolamine patch act through distinct pathways, while also addressing reversible triggers such as hypotension, pain, opioid load, and early oral intake before they compound.